Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Capsule Pegabalin 75 mg: Capsule Pregabalin 75mg will be given to Group A two hours prior to surgery.
Intervention2: Capsule Pregabalin 150mg: Capsule Pregabalin 150 mg will be given to
Sponsors
Dr. Pooja K Subbiah
Eligibility
Inclusion criteria
Inclusion criteria: 1) ASA (American Society of Anaesthesiologist) physical status 1 and 2 (ASA 1- healthy patients, ASA 2- Patients with mild to moderate systemic disease which is well under control) 2)Patients for MRM (Modified Radical Mastectomy) +/- Axillary clearance 3)Patients for breast conservative surgery.
Exclusion criteria
Exclusion criteria: 1) Allergy to Pregabalin 2)Patients not willing to participate in the study. 3)Patients having history of vertigo, dizziness. 4)ASA physical status 3 and above(ASA 3- Patients with severe systemic disease, ASA 4-Patients with severe systemic disease that is a constant threat to life, ASA 5- moribund patient who is not expected to survive, ASA 6-declared brain dead patient.) 5)Patients coming for Redo surgery. 6)Patients who have received radiation 7)Patients allergic to Inj. Diclofenac 8) Patients already on Tab.Pregabalin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure postoperative pain by VAS score and analgesic requirement among breast cancer patients receiving either Capsule Pregabalin 75mg or Capsule Pregabalin 150 mg.Timepoint: Postoperative pain by VAS score (visual analogue score) at 0,1, 2,4,8,12,24hrs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative sedation, nausea vomitting(PONV), dizziness.Timepoint: At Postoperative 1,2,4,8,12,24hrs | — |
Countries
India
Contacts
Public ContactDr Pooja K Subbiah
P.D.Hinduja Hospital
Outcome results
None listed